Huons, a South Korean pharmaceutical company specializing in ophthalmic and injectable medicines, said Thursday it has received Investigational New Drug approval from the Ministry of Food and Drug Safety to begin a Phase 2 clinical trial of its dry eye treatment candidate.
HUC1-394 is a
Continue Reading on The Korea Herald
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.